Fig. 2From: Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experienceKaplan-Meier curves on progression-free survival (PFS) and overall survival (OS) with regard to Ann Arbor staging (a, b) and age-adjusted international prognostic index (c, d)Back to article page